Reaction
Lagophthalmos reporting signals
As of the last recalculation, Lagophthalmos appears in 405 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is BUPIVACAINE (PRR 178.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bupivacaine | 30 | 178.1 | 178.7 |
| Adrenalinum | 55 | 78.7 | 78.8 |
| Onabotulinumtoxina | 83 | 69.3 | 69.3 |
| Lidicaine | 43 | 50.4 | 50.5 |
| Burn Relief | 43 | 50.4 | 50.5 |
| Lidocaine Hydrochloride And Epinephrine | 43 | 50.3 | 50.4 |
| Carboxymethylcellulose Sodium | 9 | 50.3 | 50.4 |
| Epinephrine | 55 | 49.8 | 49.8 |
| Lidocaine, Menthol | 43 | 49.7 | 49.8 |
| Botulinum Toxin Type A | 11 | 46.8 | 46.8 |
| Lidocaine Hydrochloride And Epinephrine Bitartrate | 43 | 46.2 | 46.2 |
| Lidocaine 4% | 43 | 45.3 | 45.3 |
| Lidocaine | 43 | 42.3 | 42.3 |
| Cenegermin-Bkbj | 4 | 17.2 | 17.2 |
| Lifitegrast | 4 | 12.7 | 12.7 |